Efficacy and safety of neoadjuvant chemotherapy with toripalimab in locally advanced nasopharyngeal carcinoma: a phase II trial and biological correlate analysis
Efficacy and safety of neoadjuvant chemotherapy with toripalimab in locally advanced nasopharyngeal carcinoma: a phase II trial and biological correlate analysis. // eClinicalMedicine. – URL: https://www.sciencedirect.com/science/article/pii/S2589537026005699?dgcid=rss_sd_all
Efficacy and safety of neoadjuvant chemotherapy with toripalimab in locally advanced nasopharyngeal carcinoma: a phase II trial and biological correlate analysis. eClinicalMedicine. https://www.sciencedirect.com/science/article/pii/S2589537026005699?dgcid=rss_sd_all
“Efficacy and safety of neoadjuvant chemotherapy with toripalimab in locally advanced nasopharyngeal carcinoma: a phase II trial and biological correlate analysis.” eClinicalMedicine.
@article{article43922,
title = {Efficacy and safety of neoadjuvant chemotherapy with toripalimab in locally advanced nasopharyngeal carcinoma: a phase II trial and biological correlate analysis},
journal = {eClinicalMedicine},
url = {https://www.sciencedirect.com/science/article/pii/S2589537026005699?dgcid=rss_sd_all}
}
ABSTRACT As leadership education continues to evolve, increasing attention has been given to fostering learners’ leadership identity, capacity, and efficacy. Drawing on collaborative conversations with 12 leadership educators...